Investors We Track
Andreessen Horowitz: Investing in, and nurturing, great capabilities for the enterprise
Andreessen Horowitz has a model unlike any other Venture Capital firm, and that model is paying off for a broad ecosystem of companies, investors and enterprise IT professionals. From the standpoint … [Read More...] about Andreessen Horowitz: Investing in, and nurturing, great capabilities for the enterprise
Blockchain Capital: One of the earliest and most active investors in blockchain technologies
Founded in 2013, Blockchain Capital is one of the earliest and most active investors in the blockchain technology industry and the crypto ecosystem. Blockchain Capital has raised and deployed several … [Read More...] about Blockchain Capital: One of the earliest and most active investors in blockchain technologies
Datatribe: a new kind of startup studio
Datatribe is unique. It seems like a VC firm, it makes investments. But it is run more like a company focused on building businesses. It also seems like a startup accelerator/incubator, providing … [Read More...] about Datatribe: a new kind of startup studio
JC2 Ventures: John Chambers’ New VC Fund
John Chambers is widely known as one of the great visionaries of IT, helping us all better understand the power and potential of what can be. He led Cisco Systems through exciting periods as they … [Read More...] about JC2 Ventures: John Chambers’ New VC Fund
Scaleworks: A new model of finance they call “Venture Equity”
Scaleworks has a unique model for investing in and scaling companies they call Venture Equity. They seek to acquire B2B SaaS product companies and then invest in the people and scale good companies to … [Read More...] about Scaleworks: A new model of finance they call “Venture Equity”
a16z on Twitter
This is a dynamically generated feed from the official company account:
CTO JR Rivers wrote an article for @NetworkWorld where he underlines the reasons you should be learning Linux: https://t.co/Fzq9mZlh0m
"Benchling’s DNA sequence editor played a huge part. Every DNA construct was designed and ordered via Benchling." Benchling powered Theo Roth's CRISPR research, which was published in July in this Nature paper: https://t.co/7gPq0Ey8p4
"These programmable cells could be the next generation of treatments." @rajarsrinivas @asimov_io #forbes30under30 in Healthcare https://t.co/1aodJsWEN8
Honored to represent @asimov_io in the 2019 @Forbes #ForbesUnder30 class in healthcare alongside some really amazing founders and scientists
Congratulations to my @a16z partner @JeffreyLowMD on making the #ForbesUnder30 2019 Venture Capital list! https://t.co/COby1DKMwj
This is where my perspective differs from @Dereklowe , as I've seen companies being successful with these approaches -- my examples weren't science fiction but reflect what's happening. No doubt there is still much work to do to bring these to market, but that work is in motion. https://t.co/vbe8Scmi9T
@martin_casado 3. The whole idea is that somehow sales people are a perishable commodity, and should be used and thrown out by a certain date is why we end up with mercenary sales teams.
My views haven't changed since I wrote this in 2014. https://t.co/eO1yAMlWUS
All of this and more points in the deck! Hope you enjoy it. Here's the link again: https://t.co/74fgUkdFTm. Feedback appreciated.
4) When picking projects, an important lever is reach. All the users not using your product, not active, not engaged. They represent most of of your users and folks on the planet.
3) There are multiple organizational structures to put this all together. One is to treat Growth as a BU - this is what we did at early Uber and how Facebook is run. More common is to tuck it into the product team. (More options discussed in the deck)
